Remove companies seagen-inc
article thumbnail

Seagen Stock Soars On Pfizer Takeover Talks: What's Going On?

Benzinga

Seagen Inc (NASDAQ: SGEN ) shares are trading higher Monday following reports indicating pharmaceutical giant Pfizer Inc (NYSE: PFE ) is considering acquiring the biotech company. There is no guarantee that a deal will be reached.

98
article thumbnail

Seagen's $43B Deal To Double Pfizer's Early-Stage Oncology Pipeline, Seagen Says Is Right Step

Benzinga

Pfizer Inc (NYSE: PFE ) has agreed to acquire Seagen Inc (NASDAQ: SGEN ) for $229 in cash per Seagen share for a total enterprise value of $43 billion. As per a Wall Street Journal report, the companies were in early talks with a deal valuing over Full story available on Benzinga.com

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pfizer Invests $43 Billion to Battle Cancer

Business Wire M&A

BUSINESS WIRE)--Pfizer Inc. NYSE: PFE) and Seagen Inc. The Boards of Directors of both companies have unanimously approved the transaction. NEW YORK & BOTHELL, Wash.--(BUSINESS Pfizer is dep

article thumbnail

Pfizer In Early Talks To Buy Cancer-Focused Seagen: WSJ

Benzinga

Pfizer Inc (NYSE: PFE ) is in early discussions to purchase biotechnology company Seagen Inc (NASDAQ: SGEN ), The Wall Street Journal reported late on Sunday, citing people familiar with the matter. The deal would reportedly be valued at more than $30 billion and will help Pfizer. Full story available on Benzinga.com

98
article thumbnail

Why Merck Is Sending Seagen Stock Higher Today

Benzinga

Seagen Inc (NASDAQ: SGEN ) shares are trading higher Thursday following reports suggesting Merck & Company Inc (NYSE: MRK ) is in advanced talks to acquire the company. According to a Wall Street Journal report citing people familiar with the matter, the two companies are.

98
article thumbnail

The Daily Biotech Pulse: Merck's Seagen Buyout Advances, Adverum Restructures, Pharmacists Get OK To Prescribe Pfizer COVID-19 Pill

Benzinga

Merck's Potential Buyout Of Seagen Expected Within Next Few Weeks. Merck & Co Inc. NYSE: MRK ) is in advanced talks to acquire Seagen Inc. The FDA placed a clinical hold on DiaMedica Therapeutics Inc.'s NASDAQ: SGEN ). FDA Institutes Clinical Hold On DiaMedica's Late-Stage Stroke Trial. lower at $1.29

98
article thumbnail

Taxation With Representation: Wachtell, Sullivan, Cleary

Law 360 M&A

In this week's Taxation With Representation, Pfizer agreed to acquire Seagen, Silver Lake Capital and the Canada Pension Plan Investment Board said they'll acquire Qualtrics, Apollo Global Management Inc. affiliate-managed funds agreed to buy Univar Solutions Inc.,

75